FDA halts sale of some over-the-counter hand, body wash products

Before you go, we thought you'd like these...
Before you go close icon

FDA Orders Antibacterials Removed From Consumer Soaps



Sept 2 (Reuters) - The U.S. Food and Drug Administration on Friday banned some over-the-counter antibacterial hand and body wash products, saying they are no more effective than soap and water and could cause long-term harm.

The move affects 2,100 products, or roughly 40 percent of the over-the-counter antibacterial soap market, Dr. Theresa Michele, director of the FDA's division of nonprescription drug products, told reporters on a conference call.

The ruling does not affect alcohol-based hand sanitizers or antibacterial products used in hospitals and clinics.

The agency said it is banning products that contain any one of 19 ingredients that have not been proven safe.

SEE ALSO: FDA issues warning about combined use of opioids and tranquilizers

Johnson & Johnson, Procter & Gamble Co and Colgate-Palmolive Co have said they have either reformulated or are reformulating their products to delete the most common of the 19 ingredients, including triclosan and triclocarban.

FDA spokeswoman Andrea Fischer and Brian Sansoni, of the American Cleaning Institute, which represents multiple cleaning products companies, were unable to identify the products most affected by Friday's ruling.

The FDA had proposed banning the ingredients in 2013 unless companies could prove they were safe and effective, but was unsatisfied with the data. The ACI, whose members include Dial Corp., a unit of Germany's Henkel, insists the products are effective.

More: FDA bans anti-bacterial soaps and products

5 PHOTOS
FDA bans anti-bacterial soaps and products
See Gallery
FDA bans anti-bacterial soaps and products
FILE - This Wednesday, April 29, 2009, file photo, shows hand sanitizer on a shelf at a pharmacy in Plano, Texas. Federal health officials want to know whether hand sanitizers used by millions of Americans are as effective at fighting germs as manufacturers claim, and whether there are any health risks to their use. (AP Photo/Donna McWilliam, File)
This Tuesday, April 30, 2013, photo, shows Dawn Ultra antibacterial soap in a kitchen Tuesday in Chicago. Federal health regulators are deciding whether triclosan, the germ-killing ingredient found in an estimated 75 percent of anti-bacterial liquid soaps and body washes sold in the U.S. is harmful. The ruling, which will determine whether triclosan continues to be used in household cleaners, could have broader implications for a $1 billion industry that includes hundreds of anti-bacterial products from toothpaste to toys (AP Photo/Kiichiro Sato)
Not enough science to show OTC antibacterial soaps are better at preventing illness than plain soap & water. https://t.co/pFLCvMFgqd
Wide use of these products over a long time has raised the question of potential negative effects on your health. https://t.co/RrESvJTl9a
of
SEE ALL
BACK TO SLIDE
SHOW CAPTION +
HIDE CAPTION

"Clearly this is an industry that needed a good, swift kick in the triclosan. It took far too long," said Alex Formuzis, of Environmental Working Group, a nonprofit environmental research organization.

Thomas DiPiazza, a spokesman for Colgate-Palmolive, said none of the company's products in the continental United States are affected, although a "small quantity of our bar soap in Puerto Rico, where FDA rules also apply, is being reformulated."

Procter & Gamble spokeswoman Tressi Rose said it will replace "a few" products well in advance of the FDA's deadline for removing or reformulating the products a year from now.

The regulator also deferred by a year a ruling on three additional ingredients used in consumer wash products - benzalkonium chloride, benzethonium chloride and chloroxylenol (PCMX) - to allow for the submission of new safety and effectiveness data for those ingredients.

Consumer antibacterial washes containing those specific ingredients may be sold during this time, the FDA said.

Manufacturers are conducting research to fill data gaps identified by the FDA, Sansoni said.

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners